Amifloxacin
Alternative Names: WIN 49375; WIN 49375-3Latest Information Update: 11 Aug 2009
At a glance
- Originator Sanofi Winthrop
- Developer Sanofi Winthrop; Yamanouchi
- Class Antibacterials; Fluoroquinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gram-negative infections; Septic shock; Urinary tract infections
Most Recent Events
- 30 Nov 1995 Discontinued-I for Septic shock in Japan (IV)
- 30 Nov 1995 Discontinued-I for Urinary tract infections in Japan (PO)
- 30 Nov 1995 Discontinued-II for Septic shock in USA (IV)